[1] Xiang B, Chen L, Wang X, et al. Mesenchymal stem cells as therapeutic agents and in gene delivery for the treatment of glioma. J Zhejiang Univ Sci B.2017;18(9):737-746.[2] 赖华生,陈志浩,陈祎招.神经胶质瘤与新型抑癌基因的研究进展[J].广东医学,2015,36(7):1122-1124.[3] 谢炯.人脐带间充质干细胞作为细胞载体治疗胶质瘤的研究现状及前景[D].石家庄:河北医科大学,2017.[4] Wu J, Izpisua Belmonte JC. Stem Cells: A Renaissance in Human Biology Research. Cell. 2016;165(7):1572-1585. [5] Serakinci N, Fahrioglu U, Christensen R. Mesenchymal stem cells, cancer challenges and new directions. Eur J Cancer. 2014;50(8):1522-1530. [6] Baghaban Eslaminejad M, Malakooty Poor E. Mesenchymal stem cells as a potent cell source for articular cartilage regeneration. World J Stem Cells. 2014;6(3):344-354. [7] Fellows CR, Matta C, Zakany R, et al. Adipose, Bone Marrow and Synovial Joint-Derived Mesenchymal Stem Cells for Cartilage Repair. Front Genet. 2016;7:213. [8] n 't Anker PS, Scherjon SA, Kleijburg-van der Keur C, et al. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells. 2004;22(7):1338-1345.[9] Ding DC, Chang YH, Shyu WC, et al. Human umbilical cord mesenchymal stem cells: a new era for stem cell therapy. Cell Transplant. 2015;24(3):339-347. [10] 李慎杰,周杰,张苓,等.间充质干细胞治疗胶质瘤的研究进展[J].广东医学,2016,37(19):2982-2984.[11] 梁硕,焦红亮,迟连凯,等.人脐带间充质干细胞对神经胶质瘤生长的抑制[J].中国组织工程研究,2012,16(49):9179-9185.[12] Aboody KS, Brown A, Rainov NG, et al. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci U S A. 2000;97(23):12846-12851.[13] 冉黎婧,史明霞,洪敏.间充质干细胞归巢机制研究进展[J].医学研究生学报,2014,27(4):423-426.[14] Nakamura K, Ito Y, Kawano Y, et al. Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther. 2004;11(14):1155-1164.[15] Fan C, Wang D, Zhang Q, et al. Migration capacity of human umbilical cord mesenchymal stem cells towards glioma in vivo. Neural Regen Res. 2013;8(22):2093-2102. [16] Li CH, Jiao BH, Kang CS, et al. The Preliminarystudy on the Bone marmw derived mesenehymal stem cells migratingtoward glioma. Chin J Nery Ment Dis. 2006;32:289-293.[17] HoWangYin KY, Loinard C, Bakker W, et al. HIF-prolyl hydroxylase 2 inhibition enhances the efficiency of mesenchymal stem cell-based therapies for the treatment of critical limb ischemia. Stem Cells. 2014;32(1):231-243. [18] 范冬梅,张子祥,赵英新,等.人脐带来源间充质干细胞向HepG2肝癌细胞原位移植瘤的归巢及分化[J].中国肿瘤生物治疗杂志, 2017,24(6):595-600.[19] Bonora M, Wieckowski MR, Chinopoulos C, et al. Molecular mechanisms of cell death: central implication of ATP synthase in mitochondrial permeability transition. Oncogene. 2015; 34(12):1475-1486.[20] Rombouts WJ, Ploemacher RE. Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture. Leukemia. 2003;17(1):160-170.[21] 张艺凡,胡方方,秦方圆,等.人脐带间充质干细胞与肿瘤治疗研究进展[J].中华实用诊断与治疗杂志,2017,31(4):403-406..[22] Watson N, Divers R, Kedar R, et al. Discarded Wharton jelly of the human umbilical cord: a viable source for mesenchymal stromal cells. Cytotherapy. 2015;17(1):18-24.[23] Thibeault S, Rautureau Y, Oubaha M, et al. S-nitrosylation of beta-catenin by eNOS-derived NO promotes VEGF-induced endothelial cell permeability. Mol Cell. 2010;39(3):468-476. [24] Chen J, Liu Z, Hong MM, et al. Proangiogenic compositions of microvesicles derived from human umbilical cord mesenchymal stem cells. PLoS One. 2014;9(12):e115316. [25] Kim DS, Kim JH, Lee JK, et al. Overexpression of CXC chemokine receptors is required for the superior glioma-tracking property of umbilical cord blood-derived mesenchymal stem cells. Stem Cells Dev. 2009;18(3): 511-519. [26] 范存刚,周景儒,张庆俊.人脐带血来源的间充质干细胞在脑胶质瘤治疗中的应用前景[J].国际神经病学神经外科学杂志,2011, 38(6):598-602.[27] Dasari VR, Kaur K, Velpula KK, et al. Upregulation of PTEN in glioma cells by cord blood mesenchymal stem cells inhibits migration via downregulation of the PI3K/Akt pathway. PLoS One. 2010;5(4):e10350. [28] Akimoto K, Kimura K, Nagano M, et al. Umbilical cord blood-derived mesenchymal stem cells inhibit, but adipose tissue-derived mesenchymal stem cells promote, glioblastoma multiforme proliferation. Stem Cells Dev. 2013; 22(9):1370-1386. [29] Doucette T, Rao G, Yang Y, et al. Mesenchymal stem cells display tumor-specific tropism in an RCAS/Ntv-a glioma model. Neoplasia. 2011;13(8):716-725.[30] 刘晓智,姜忠敏.成体干细胞作为药物载体治疗胶质瘤的作用途径研究进展[J].山东医药,2016,56(43):101-104.[31] Kim SM, Jeong CH, Woo JS, et al. In vivo near-infrared imaging for the tracking of systemically delivered mesenchymal stem cells: tropism for brain tumors and biodistribution. Int J Nanomedicine. 2015;11:13-23.[32] Wu GS. TRAIL as a target in anti-cancer therapy. Cancer Lett. 2009;285(1):1-5. [33] Yang B, Wu X, Mao Y, et al. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells. Neurosurgery. 2009;65(3):610-624; discussion 624. [34] Park JH, Ryu CH, Kim MJ, et al. Combination Therapy for Gliomas Using Temozolomide and Interferon-Beta Secreting Human Bone Marrow Derived Mesenchymal Stem Cells. J Korean Neurosurg Soc. 2015;57(5):323-328. [35] Xu G, Jiang XD, Xu Y, et al. Adenoviral-mediated interleukin-18 expression in mesenchymal stem cells effectively suppresses the growth of glioma in rats. Cell Biol Int. 2009;33(4):466-474.[36] Lozito TP, Tuan RS. Mesenchymal stem cells inhibit both endogenous and exogenous MMPs via secreted TIMPs. J Cell Physiol. 2011;226(2):385-396. [37] 郭兴荣,王小莉,袁雅红,等.PTEN mRNA编辑的间充质干细胞对神经胶质瘤U251细胞杀伤作用研究[J].生物技术通报,2016, 32(4):234-241.[38] 田毅,关方霞,胡祥,等.人脐带沃顿胶间充质干细胞与脑肿瘤干细胞的共培养[J].中国组织工程研究与临床康复,2010,14(10): 1721-1728.[39] Jiao H, Guan F, Yang B, et al. Human amniotic membrane derived-mesenchymal stem cells induce C6 glioma apoptosis in vivo through the Bcl-2/caspase pathways. Mol Biol Rep. 2012;39(1):467-473. [40] 粱阿铭,梁硕,樊锐太,等.直接和间接共培养条件下人脐带间充质干细胞对恶性胶质瘤细胞系SHG44生长的抑制作用[J].中国组织工程研究,2012,16(32):5891-5896.[41] Fonseka M, Ramasamy R, Tan BC, et al. Human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSC) inhibit the proliferation of K562 (human erythromyeloblastoid leukaemic cell line). Cell Biol Int. 2012;36(9):793-801. [42] 靳晓亮.人羊膜及脐带间充质干细胞与C6胶质瘤细胞分别共培养的实验研究[D].郑州:郑州大学,2009.[43] 汪玲.肿瘤微环境中hUC-MSCs的生物学特性分析[D].重庆:重庆医科大学,2016.[44] 王娜,陈乃耀.脐带间充质干细胞对小胶质细胞增殖及活化的影响[J].山东大学学报(医学版),2016,54(10):16-20.[45] 芦慧颖,杜文敬,刘春香,等.二次贴壁法高效制备人脐带间充质干细胞[J].中国生物制品学杂志,2017,30(6):649-654.[46] 谢长峰,杜杰,曾桂芳,等.人脐带间充质干细胞对裸鼠的促瘤和致瘤性研究[J].中华细胞与干细胞杂志(电子版),2016,6(6): 356-362.[47] Wang Y, Han ZB, Ma J, et al. A toxicity study of multiple-administration human umbilical cord mesenchymal stem cells in cynomolgus monkeys. Stem Cells Dev. 2012; 21(9):1401-1408. [48] 张文祥,王思平,锡洪敏,等.Wistar 大鼠肌肉注射异种脐带间充质干细胞的安全性[J].中国组织工程研究,2014,18(41): 6620-6627.[49] 孙丽.人脐带间充质干细胞来源exosomes的安全性评价[D].镇江:江苏大学,2016.[50] 韩丽鑫,韩之波,耿洁,等.脐带间充质干细胞对乳腺癌细胞系MCF-7裸鼠移植瘤生长的影响[J].中国组织工程研究,2015, 19(19):2986-2992.[51] Centeno CJ, Schultz JR, Cheever M, et al. Safety and complications reporting update on the re-implantation of culture-expanded mesenchymal stem cells using autologous platelet lysate technique. Curr Stem Cell Res Ther. 2011;6(4): 368-378.[52] 杨华强,张荣环,李红,等.鞘内注射脐带间充质干细胞治疗神经系统疾病的安全性和疗效研究(英文)[J].现代生物医学进展,2015, 15(15):2913-2917.[53] 刘高米洋,朱慧,何洁,等.脐带间充质干细胞对胶质瘤细胞转移侵袭能力影响初探[J].西南国防医药,2016,26(12):1398-1400.[54] 刘高米洋,和法莲,陈慧芬,等.人脐带间充质干细胞对胶质瘤细胞株U87上皮间质转化及皮下荷瘤能力的影响[J].中华细胞与干细胞杂志(电子版),2016,6(6):369-375.[55] 陈榕,江涛,杨爱珍,等.人脐带间充质干细胞应用于肝移植患者的观察[J].中国组织工程研究,2017,21(17):2665-2671. |